טוען...
Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?
Primary liver cancers are a heterogenous collection of diseases with variable natural histories and treatments. This review article will focus on hepatocellular carcinoma (HCC), intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder cancer, and the use of immune checkpoint inhibitors (ICI...
שמור ב:
| הוצא לאור ב: | Transl Gastroenterol Hepatol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AME Publishing Company
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7061229/ https://ncbi.nlm.nih.gov/pubmed/32190776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2019.09.07 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|